SB292: An Act To Amend Title 16 Of The Delaware Code Relating To Naloxone And Other Opioid Antagonists.

Legislative Summary

An opioid antagonist is a medication approved by the United States Food and Drug Administration (FDA) for emergency reversal of a known or suspected opioid overdose. Currently, naloxone is the only FDA-approved opioid antagonist, however, the FDA is expected to approve at least 1 new, more powerful opioid antagonist in 2022.